PICALM Gene Therapy and Drug Screening for Amyloid Beta Clearance (Year 3)
PICALM is highly associated with late-onset AD based on genome-wide association studies. PICALM facilitates clathrin-mediated endocytosis and regulates the internalization and intracellular trafficking of cell surface receptors. Its N-terminus contains an epsin NH2-terminal homology domain for phosphatidylinositol-4,5-bisphosphate binding, which allows PICALM to sense membrane curvatures and regulate the size of ...
June 19, 2018